Item Type | Name |
Academic Article
|
Editorial comment.
|
Academic Article
|
Editorial comment.
|
Concept
|
Prostate-Specific Antigen
|
Concept
|
Prostate
|
Academic Article
|
Population-Based Assessment of Determining Treatments for Prostate Cancer.
|
Academic Article
|
What Have Patients Been Hearing From Providers Since the 2012 USPSTF Recommendation Against Routine Prostate Cancer Screening?
|
Academic Article
|
Patterns of care related to age of men with prostate cancer.
|
Academic Article
|
Estimating the cost effectiveness of total androgen blockade with flutamide in M1 prostate cancer.
|
Academic Article
|
Performance measurement in prostate cancer care: beyond report cards.
|
Academic Article
|
Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers?
|
Academic Article
|
Treatment considerations for persons with metastatic prostate cancer: survival versus out-of-pocket costs.
|
Academic Article
|
Approaches to prostate cancer by managed care organizations.
|
Academic Article
|
A comparison of perspectives on prostate cancer: analysis of utility assessments of patients and physicians.
|
Academic Article
|
Comparison of perspectives on prostate cancer: analyses of survey data.
|
Academic Article
|
Variations in the use of prostate cancer staging tests: results from one NCCN Institution.
|
Academic Article
|
Prostate cancer patients' utilities for health states: how it looks depends on where you stand.
|
Academic Article
|
Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer.
|
Academic Article
|
Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures.
|
Academic Article
|
Pilot study of a utilities-based treatment decision intervention for prostate cancer patients.
|
Academic Article
|
Agreement between prostate cancer patients and their clinicians about utilities and attribute importance.
|
Academic Article
|
American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.
|
Academic Article
|
Ethnic variation in localized prostate cancer: a pilot study of preferences, optimism, and quality of life among black and white veterans.
|
Academic Article
|
Patient preferences in prostate cancer: a clinician's guide to understanding health utilities.
|
Academic Article
|
Opportunities for disease state management in prostate cancer.
|
Academic Article
|
Caveat medicus: consequences of federal investigations of marketing activities of pharmaceutical suppliers of prostate cancer drugs.
|
Academic Article
|
Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer.
|
Academic Article
|
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline.
|
Academic Article
|
Proxy assessment of health-related quality of life in african american and white respondents with prostate cancer: perspective matters.
|
Academic Article
|
The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer.
|
Academic Article
|
Sildenafil- and tadalafil-associated optic neuropathy: implications for men after prostate cancer treatment.
|
Academic Article
|
Invited commentary: Prostate cancer: doing less might be more. Comment on "Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer".
|
Academic Article
|
Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer.
|
Academic Article
|
Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone.
|
Academic Article
|
Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance.
|
Academic Article
|
Angiotensin receptor blockers and risk of prostate cancer among United States veterans.
|
Academic Article
|
The utility of prostate-specific antigen in the management of advanced prostate cancer.
|
Academic Article
|
Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline.
|
Academic Article
|
The association between race and treatment regret among men with recurrent prostate cancer.
|
Academic Article
|
Geography: an increasingly important variable in prostate cancer clinical trials.
|
Academic Article
|
High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy?
|
Academic Article
|
Editorial Comment.
|
Academic Article
|
Association Between Androgen Deprivation Therapy and Patient-reported Depression in Men With Recurrent Prostate Cancer.
|
Academic Article
|
A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer.
|
Academic Article
|
Patient- and area-level predictors of prostate cancer among South Carolina veterans: a spatial analysis.
|
Academic Article
|
QOL and outcomes research in prostate cancer patients with low socioeconomic status.
|
Academic Article
|
A multi-attribute model of prostate cancer patient's preferences for health states.
|
Academic Article
|
Quality of life in low-income patients with metastatic prostate cancer: divergent and convergent validity of three instruments.
|
Academic Article
|
Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis.
|
Academic Article
|
Maximal androgen blockade for advanced prostate cancer.
|
Academic Article
|
Comparative study of the clinical efficacy of two dosing regimens of flutamide.
|
Academic Article
|
Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.
|
Academic Article
|
Spouse ratings of quality of life in patients with metastatic prostate cancer of lower socioeconomic status: an assessment of feasibility, reliability, and validity.
|
Academic Article
|
Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review.
|
Academic Article
|
Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma.
|
Academic Article
|
Maximum androgen-blockade with medical or surgical castration in advanced prostate cancer: A meta-analysis of nine published randomized controlled trials and 4128 patients using flutamide.
|
Academic Article
|
Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes Study.
|
Academic Article
|
Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update.
|
Academic Article
|
Do radiation oncologists and urologists endorse decision aids for active surveillance of low-risk prostate cancer: Results from a national survey.
|
Academic Article
|
A spatial assessment of prostate cancer mortality-to-incidence ratios among South Carolina veterans: 1999-2015.
|
Academic Article
|
Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases.
|